By Sabela Ojea

 

RUA Life Sciences PLC said Wednesday that the RUA Vascular business has submitted its premarket notification for a range of polymerically sealed vascular grafts to the U.S. Food and Drug Administration.

The developer of polymer materials for medical devices said the submission follows an introduction of the RUA graft at the recent annual meeting of the European Association for Cardio-Thoracic Surgery, held in Barcelona, Spain.

Shares at 0912 GMT were up 10.00 pence, or 6.6%, at 161.50 pence.

 

Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix

 

(END) Dow Jones Newswires

November 03, 2021 05:33 ET (09:33 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.
Aortech (LSE:AOR)
Gráfica de Acción Histórica
De Abr 2024 a May 2024 Haga Click aquí para más Gráficas Aortech.
Aortech (LSE:AOR)
Gráfica de Acción Histórica
De May 2023 a May 2024 Haga Click aquí para más Gráficas Aortech.